Together, these data proved that miR-31, at least partially activated RAF-MEK-ERK and PI3K-AKT signaling pathways by directly repressing RASA1 and FIH-1 in NSCLC cells. This evidence concerns the gene MAP2K7 and non-small cell lung carcinoma.